TY  - JOUR
AU  - Pérez-Valero, Ignacio
AU  - González-Baeza, Alicia
AU  - Estébanez, Miriam
AU  - Montes-Ramírez, María L
AU  - Bayón, Carmen
AU  - Pulido, Federico
AU  - Bernardino, Jose Ignacio
AU  - Zamora, Francisco X
AU  - Monge Corella, Susana
AU  - Gaya, Francisco
AU  - Lagarde, María
AU  - Rubio, Rafael
AU  - Hernando, Asunción
AU  - Arnalich, Francisco
AU  - Arribas, José Ramón
PY  - 2013
DO  - 10.1371/journal.pone.0069493
SN  - 1932-6203
UR  - http://hdl.handle.net/20.500.12105/6801
AB  - BACKGROUND: In patients who remain virologically suppressed in plasma with triple-drug ART a switch to protease inhibitor monotherapy maintains high rates of suppression; however it is unknown if protease inhibitor monotherapy is associated to a...
LA  - eng
PB  - Public Library of Science (PLOS)
KW  - AIDS Dementia Complex
KW  - Adult
KW  - Cross-Sectional Studies
KW  - Darunavir
KW  - Drug Administration Schedule
KW  - Drug Resistance, Viral
KW  - Female
KW  - HIV Protease Inhibitors
KW  - HIV-1
KW  - Humans
KW  - Lopinavir
KW  - Male
KW  - Middle Aged
KW  - Neuropsychological Tests
KW  - Ritonavir
KW  - Sulfonamides
KW  - Viral Load
KW  - Antiretroviral Therapy, Highly Active
TI  - Neurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapy
TY  - journal article
ER  -